Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2010
11/10/2010EP1704160B1 Methods and compositions for identifying rna-binding proteins
11/10/2010EP1697545B1 Multiplex nucleic acid analysis of HPV genotypes
11/10/2010EP1030867B1 Mammalian milk growth factor
11/10/2010CN1775946B Enhanced virus-mediated DNA transfer
11/10/2010CN101883784A N-terminal modified interferon-alpha
11/10/2010CN101883777A Antisense modulation of fibroblast growth factor receptor 4 expression
11/10/2010CN101883776A Apparatus, system, and method for purifying nucleic acids
11/10/2010CN101883747A Bisulphite treatment of RNA
11/10/2010CA2759233A1 Method for making heteromultimeric molecules
11/09/2010US7829770 Inbred corn line MN7
11/09/2010US7829769 Inbred corn line XHH12
11/09/2010US7829768 Tomato variety EX01419137
11/09/2010US7829761 Scarecrow-like stress-related polypeptides and methods of use in plants
11/09/2010US7829696 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA
11/09/2010US7829695 Specific GRP78 expression-inhibition RNAi sequence, medicine thereof and method thereof
11/09/2010US7829694 surgerical insertion of catheter; supplying protein antagonistl Alzheimer's disease; Parkinson's disease; Huntington's disease; Spinocerebella atropy
11/09/2010US7829693 Compositions and methods for inhibiting expression of a target gene
11/09/2010US7829692 Primer composition and a kit useful for the identification of phyllanthus
11/09/2010US7829691 Detection of nucleic acids by type specific hybrid capture method
11/09/2010US7829690 Non-coding regulatory element polynucleotide molecules isolated from a nopaline synthase gene and vitopine synthase gene of Agrobacterium vitis are useful for expressing transgenes in plants
11/09/2010US7829689 Regulation of translation of heterologously expressed genes
11/09/2010US7829688 nucleic acid encoding peptide that inhibits the interaction of CaV2.2 with Mint1-PDZ1, a glutathione S transferase fusion protein; neurotransmitter-release angonists of CaV2.2, the pore-forming subunit of N-type of voltage-dependent calcium channels; antinocciceptive agents
11/09/2010US7829687 comprising an N-terminal domain derived from E. coli FkpA that allows for dimerization and provides a substrate binding region, and a C-terminal thioredoxin domain derived from E. coli DsbA
11/09/2010US7829686 Nucleic acid encoding a subunit of Na+,K+-ATPase
11/09/2010US7829685 Regulation of kinase, regulated in COPD kinase (RC kinase)
11/09/2010US7829682 human kinases and phosphatases (KPP) and polynucleotides which identify and encode KPP; for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP
11/09/2010US7829671 human endonuclease protein, MED1 (methyl-CpG binding endonuclease 1); drug screening; genetic or cancer screening assays
11/09/2010US7829547 inhibition of the expression of SCCA (squamous cell carcinoma antigen) by cells is carried out by RNA interference of a gene encoding SCCA, and wherein the RNA interference uses a double-stranded RNA comprising a sense oligonucleotide strand or mutant; inhibits cysteine protease inhibitory activity
11/09/2010US7829545 Bladder and lower urinary tract syndromes, particularly, irrative symptoms, and to a method of treating same using alpha 1d-adrenergic receptor ( alpha 1dAR) antagonists. The invention further relates to a method of screening compounds
11/09/2010US7829536 administering to a patient with lymphedema a therapeutically effective amount of a vascular endothelial growth factor D (VEGF-D) protein at the site of edema, that binds and stimulates wild-type VEGFR-3; genetic disorders; screening
11/09/2010US7829526 DNA encoding peptide, an antibody against the peptide; cardioinhibitory, hypotensive agent; peptide as an active ingredient; marker protein, peptide tag
11/09/2010US7829348 Raman-active reagents and the use thereof
11/09/2010US7829320 Asparaginases
11/09/2010US7829317 Attachment of molecules to surfaces
11/09/2010US7829316 using a bacterium which has been modified so as to increase the expression of a sucE1 gene or a product produced by any treatment of the bacterium with an organic raw material in a reaction solution containing a carbonate ion, a bicarbonate ion or carbon dioxide gas
11/09/2010US7829288 Methods for assessing efficacy of chemotherapeutic agents
11/09/2010US7829285 diagnosing, monitoring, or predicting the conditions of pre-eclaimpsia, fetal chromosomal aneuploidy, and pre-term labor in a pregnant woman, as well as for detecting pregnancy; human corticotropin releasing hormone (hCRH)
11/09/2010US7829284 Helicase-dependent amplification of nucleic acids
11/09/2010US7829283 determining whether a human subject is suffering from melanoma cancer by determining the methylation level of the estrogen receptor-alpha (ER- alpha ) gene promoter in the acellular DNA sample; treated with a demethylation agent
11/09/2010US7829282 Methods and compositions for predicting drug responses
11/09/2010US7829281 Using polymorphic variation in neuroendocrine peptides receptor (Npy2r) genes as diagnostic tool in detection of metabolic disorders
11/09/2010US7829279 inhibiting growth of a neuronal cell comprises contacting the cell with EFHC1, EFHC1 agonist, or EFHC1 analog; juvenile myoclonic epilepsy
11/09/2010US7829277 Methods for identifying compounds that suppress chemically-induced carcinogenesis
11/09/2010US7829276 Using conditionally replication-competent adenoviruses transcription as diagnostic indicator of cell proliferative disorders of alimentary canal; tissue targeted therapy; drug delivery
11/09/2010US7829275 Target analyte supported on conductive support containing a nanoparticle comprising a photoelectrochemically active group, exposing the active group with light to generate photoelectric current, measuring the current
11/09/2010US7829086 Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
11/09/2010US7829081 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
11/09/2010CA2343102C Antisense modulation of survivin expression
11/09/2010CA2137815C Dna sequences used in the production of recombinant human bssl/cel in transgenic non-human mammals, and the produced bssl/cel used in infant formulas
11/08/2010CA2665650A1 Primers and probes for detection of influenza type a viruses of subtype h1
11/04/2010WO2010126771A1 Systems, kits and methods of identifying ocular fungal and amoebic pathogens
11/04/2010WO2010126246A2 ANTI ErbB2 RNA APTAMER AND APPLICATIONS THEREFOR
11/04/2010WO2010105097A3 Sparc angiogenic domain and methods of use
11/04/2010US20100281585 Composition and method for increasing resistance against plant pathogen by comprising bacterial genetic materials, and plant produced by the method
11/04/2010US20100281583 Boron transporter
11/04/2010US20100281582 Polypeptides having xylanase activity and polynucleotides encoding same
11/04/2010US20100281579 Methods for Improving Crop Plant Architecture and Yield
11/04/2010US20100281578 Yield Enhancement in Plants by Modulation of AP2 Transcription Factor
11/04/2010US20100281577 Plant haemoglobin
11/04/2010US20100281576 Cytochrome p450 gene for increasing seed size or water stress resistance of plant
11/04/2010US20100281573 ADS Genes For Reducing Saturated Fatty Acid Levels In Seed Oils
11/04/2010US20100281572 Nematode resistant transgenic plants
11/04/2010US20100281571 for improving fiber quality and/or yield of a fiber producing plant, as well as methods of using such polynucleotides for producing plants having increased biomass/vigor/yield
11/04/2010US20100281570 Maize 18kd oleosin seed-preferred regulatory element
11/04/2010US20100281569 Maize 17kd oleosin seed-preferred regulatory element
11/04/2010US20100281556 Genes which produce staygreen characteristics in maize and their uses
11/04/2010US20100281552 Synthetic oplophorus luciferases with enhanced light output
11/04/2010US20100281550 Factor involved in latent infection with herpesvirus, and use thereof
11/04/2010US20100281547 Selecting animals for desired genotypic or potential phenotypic properties
11/04/2010US20100280246 Energy transfer dyes with enhanced fluorescence
11/04/2010US20100280234 Photocleavable Protecting Groups and Methods for Their Use
11/04/2010US20100280233 Method for sample preparation
11/04/2010US20100280224 Marker sequences for multiple sclerosis and use thereof
11/04/2010US20100280177 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/04/2010US20100280174 Method of Manufacturing a Polymer Blend
11/04/2010US20100280134 Markers for Bladder Cancer Detection
11/04/2010US20100280114 Primers and primer sets for use in methods to detect the presence of acidovorax avenae subsp. citrulli
11/04/2010US20100280105 Detection of mage-a expression
11/04/2010US20100280102 Double-stranded ribonucleic acid with increased effectiveness in an organism
11/04/2010US20100280100 Treatment of hemoglobin (hbf/hbg) related diseases by inhibition of natural antisense transcript to hbf/hbg
11/04/2010US20100280097 Compositions comprising hif-1 alpha sirna and methods of use thereof
11/04/2010US20100280096 Treatment of influenza
11/04/2010US20100280094 Compositions and methods to treat muscular & cardiovascular disorders
11/04/2010US20100279980 Moenomycin biosynthesis-related compositions and methods of use thereof
11/04/2010US20100279975 Compounds and methods associated with differential methylation of human papilloma virus genomes in epithelial cells
11/04/2010US20100279947 Modifications of apoptin
11/04/2010US20100279919 Compositions comprising human integrin-linked kinase-sirna and methods of use thereof
11/04/2010US20100279897 Glycine N-methyltransferase (GNMT) Animal model and use thereof
11/04/2010US20100279896 siRNA Targeting Interleukin-1 Receptor-Associated Kinase 4(IRAK4)
11/04/2010US20100279895 Oligonucleotide analogues
11/04/2010US20100279889 Population scale HLA-typing and uses thereof
11/04/2010US20100279884 Primers, probes, microarray, and method for specific detection of nine respiratory disease-associated bacterial species
11/04/2010US20100279879 Method for the analysis of breast cancer disorders
11/04/2010US20100279878 Biomarkers for Septic Shock Patients
11/04/2010US20100279408 Polymeric short interfering rna conjugates
11/04/2010US20100279390 Methods for Transforming Eukaryotic Algae
11/04/2010US20100279384 Isolated reductive dehalogenase genes
11/04/2010US20100279381 Acetylcholinesterase (AChE) variants of the N-terminus
11/04/2010US20100279380 Methods for Degrading Toxic Compounds
11/04/2010US20100279378 MEK Ligands and Polynucleotides Encoding MEK Ligands
1 ... 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 ... 899